Andrew Adamovich: Ledger

Role	Organisation	Sources
CEO	AdvanCell	Forbes Australia, Startup Daily, Brandon Capital

Coverage

Stories naming Andrew Adamovich. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

Series D+ ~$452m

Brisbane biotech AdvanCell just raised a record $450 million

Brisbane radiopharmaceutical developer AdvanCell has closed an oversubscribed Series D round, led by Ally Bridge Group and Alpha Wave with several institutional investors returning, to fund late-stage prostate cancer trials and US manufacturing.

Forbes Australia 16 Jul 2026 AdvanCell AstraZeneca Bristol-Myers Squibb Novartis POINT Biopharma Ally Bridge Group Alpha Wave Bain Capital Life Sciences Brandon Capital Eli Lilly Fidelity Qatar Investment Authority (QIA)Sanofi Ventures T. Rowe Price Andrew Adamovich Philina Lee

3 deals

Cancer treatment biotech AdvanCell injects $178 million Series C

Startup Daily 13 Feb 2025 AdvanCell Eli Lilly Abingworth Brandon Capital Morningside NSW Health Medical Devices Fund Sanofi Ventures SV Health Investors SymBiosis Tenmile Andrew Adamovich Bali Muralidhar Bill Ferris Christopher Gagliardi Jamil M. Beg

Series C US$112m

AdvanCell Successfully Completes an Oversubscribed US$112M Series C Financing

Sydney cancer-therapy developer AdvanCell has completed a US$112 million Series C that was oversubscribed, co-led by four investors, with Brandon Capital among new backers; three investor representatives join the board.

Brandon Capital portfolio 3 Feb 2025 AdvanCell Abingworth Brandon Capital Morningside Sanofi Ventures SV Health Investors SymBiosis Tenmile Andrew Adamovich Bali Muralidhar Bill Ferris AC Christopher Gagliardi Jamil M. Beg

Also Startup Daily·SmartCompany·Forbes Australia

Andrew Adamovich

Roles

Coverage

Brisbane biotech AdvanCell just raised a record $450 million

Cancer treatment biotech AdvanCell injects $178 million Series C

AdvanCell Successfully Completes an Oversubscribed US$112M Series C Financing